Publications:

Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations.

Antimicrobial Agents And Chemotherapy

Oliveira, Maureen M; Moisi, Daniela D; Spira, Bonnie B; Cox, Susan S; Brenner, Bluma G BG; Wainberg, Mark A MA

Publication Date: 2009-04

Variant appearance in text: CD4: E194E

PubMed Link: 19223637

Variant Present in the following documents:

• Main text

View BVdb publication page